Form 4 for YARW Yarrow Bioscience, Inc.

Accepted 2024-01-03 00:00:00 ET · period of report 2024-01-01 · accession 0001209191-24-000470 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2024-01-03	2024-01-02	YARW	Zeronda Tyler	CFO	F - Tax	$2.28	-93	131.8K	-0.1%	-$212.04
D	2024-01-03	2024-01-01	YARW	Zeronda Tyler	CFO	A - Grant	$0.00	+62.5K	131.9K	+90%	$0
D	2024-01-03	2024-01-01	YARW	Zeronda Tyler	CFO	A - Grant	$0.00	+62.5K	62.5K	New	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2024-01-02	F	D	93	$2.28	131,837	D	—	—	(F3) Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units.
2	Common	Common Stock	2024-01-01	A	A	62,500	$0.00	131,930	D	—	—	(F1) Grant to the Reporting Person of a restricted stock unit ("RSU") award. Each RSU represents a contingent right to receive one share of common stock of the Issuer. (F2) The shares underlying the RSU vest over a period of 4 years. 25% of the shares subject to the award will vest on March 31, 2025 and 6.25% of the shares will vest on the last day of each quarter thereafter. All vesting is subject to the Reporting Person's continuous service through each applicable vesting date.
3	Derivative	Stock Option (right to buy)	2024-01-01	A	A	62,500	$0.00	62,500	D	$2.33 · — to 2033-12-31	62,500 Common Stock	(F4) The shares subject to the option vest over a period of 4 years. 25% of the shares subject to the option will vest on March 31, 2025 and 6.25% of the shares will vest on the last day of each quarter thereafter. All vesting is subject to the Reporting Person's continuous service through each applicable vesting date.